Key driver epigenetic mutations within isocitrate dehydrogenase (IDH1) are classed as causative in adult GBM, and alterations in the TP53, TERT, and ATRX genes act as common prognostic and therapeutic targets. The gene discussed is ATRX; the disease is glioblastoma.